News | May 22, 2023
GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
India’s efforts are aimed at boosting health at the last mile
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Testing supporting allergy diagnosis now accessible to more people in more communities
Subscribe To Our Newsletter & Stay Updated
